Claritev (CTEV)

Profile

Full Name

CTEV

Ticker Symbol

CTEV

Exchange

NYSE

Sector

Healthcare

Industry

Health Information Services

Country

United States

IPO

April 3, 2020

Indexes

Not included

Website

http://www.claritev.com

Employees

2700

Key Details

Price

$40.23(+1.00%)

Market cap

$661.24M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$930.62M(-3.21% YoY)

Annual EPS

-$101.92(-1691.21% YoY)

PE ratio

-

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $40.23
    CTEV price is $40.23

    30-Day Relative Volume

    0.92
    CTEV 30-day relative volume is 0.92

    Price Performance

    Price Most recent change

    +1%
    CTEV price was up +1% on Jun 17, 2025

    Price YTD change

    +172.19%
    CTEV price is up +172.19% since January 1st

    Price 1-year change

    +152.07%
    CTEV price is up +152.07% year-on-year

    Price 3-year change

    -81.48%
    CTEV price is down -81.48% over the past 3 years

    Price Range

    Price All-time high

    $517.20
    CTEV price is currently -92.22% below its historical high of $517.20

    Price 3-year low

    $4.80
    CTEV price is currently +738.13% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $661.24M
    CTEV market capitalization is $661.24 million

    Market cap 3-year change

    -80.94%
    CTEV market capitalization is down -80.94% over the past 3 years

    Market cap All-time high

    $16.13B
    CTEV market capitalization is currently -95.90% below its historical high of $16.13 billion

    Market cap sector rank

    71.59%
    CTEV market capitalization is higher than 71.59% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.95%
    CTEV shares outstanding is up +1.95% year-on-year

    Shares Outstanding 3-Year Change

    +2.89%
    CTEV shares outstanding is up +2.89% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.27
    CTEV beta is 1.27

    200-day SMA

    $17.01
    CTEV price is currently +136.45% above its 200-day simple moving average

    50-day SMA

    $27.34
    CTEV price is currently +47.17% above its 50-day simple moving average

    RSI

    70.94
    CTEV 14-day relative strength index is 70.94

    Volume

    0.92
    CTEV 30-day relative volume is 0.92

    ATR

    $2.54
    CTEV average true range is $2.54

    10-day Historical Volatility

    56.16%
    CTEV 10-day historical volatility is 56.16%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $930.62M
    CTEV annual revenue is $930.62 million

    Revenue Analysts estimate

    $928.95M
    CTEV annual revenue is currently +0.18% higher than the consensus analysts' forecast

    Revenue 1-year change

    -3.21%
    CTEV annual revenue is down -3.21% year-on-year

    Revenue Sector rank

    79.71%
    CTEV annual revenue is higher than 79.71% of companies in Healthcare sector

    EPS

    EPS

    -$101.92
    CTEV annual earnings per share is -$101.92

    EPS Analysts estimate

    -
    CTEV annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -1691.21%
    CTEV annual earnings per share is down -1691.21% year-on-year

    EPS Sector rank

    2.13%
    CTEV annual earnings per share is higher than 2.13% of companies in Healthcare sector

    Profit

    Gross profit

    $691.22M
    CTEV annual gross profit is $691.22 million

    Gross margin

    74.27%
    CTEV annual gross profit margin is 74.27%

    Operating profit

    $98.93M
    CTEV annual operating income is $98.93 million

    Operating margin

    10.63%
    CTEV annual operating profit margin is 10.63%

    Net income

    -$1.65B
    CTEV annual net profit is -$1.65 billion

    Net margin

    -176.85%
    CTEV annual net profit margin is -176.85%

    Expenses

    Total expenses

    $831.69M
    CTEV annual total expenses is $831.69 million

    Operating expenses

    $592.29M
    CTEV annual total operating expenses is $592.29 million

    Cost of goods sold

    $239.40M
    CTEV annual cost of goods sold is $239.40 million

    Selling, general & administrative expenses

    $160.22M
    CTEV annual SGA is $160.22 million

    Depreciation and amortization

    $436.44M
    CTEV annual depreciation & amortization is $436.44 million

    Interest expense

    $326.37M
    CTEV annual interest expense is $326.37 million

    Income tax

    -$124.88M
    CTEV annual income tax is -$124.88 million

    EBIT & EBITDA

    EBIT

    -$1.44B
    CTEV annual earnings before interest & taxes is -$1.44 billion

    EBITDA

    -$1.01B
    CTEV annual EBITDA is -$1.01 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.15B
    CTEV annual total assets is $5.15 billion

    Non current assets

    $4.98B
    CTEV annual long term assets is $4.98 billion

    Current assets

    $175.51M
    CTEV annual total current assets is $175.51 million

    Cash and cash equivalents

    $16.85M
    CTEV annual cash & cash equivalents is $16.85 million

    Accounts receivable

    $89.76M
    CTEV annual accounts receivable is $89.76 million

    Inventory

    -
    CTEV annual inventory value is unknown

    Liabilities

    Total liabilities

    $5.07B
    CTEV annual total liabilities is $5.07 billion

    Long term liabilities

    $4.85B
    CTEV annual total long term liabilities is $4.85 billion

    Current liabilities

    $213.79M
    CTEV annual total current liabilities is $213.79 million

    Accounts payable

    $86.33M
    CTEV annual accounts payable is $86.33 million

    Debt

    Total debt

    $4.54B
    CTEV annual total debt is $4.54 billion

    Total debt 1-year change

    -0.58%
    CTEV annual total debt is down -0.58% year-on-year

    Long term debt

    $4.52B
    CTEV annual long term debt is $4.52 billion

    Short term debt

    $17.64M
    CTEV annual short term debt is $17.64 million

    Equity & Capital

    Shareholders equity

    $84.02M
    CTEV annual stockholders equity is $84.02 million

    Book value

    $84.02M
    CTEV annual book value is $84.02 million

    Retained earnings

    -$2.15B
    CTEV annual retained earnings is -$2.15 billion

    Working capital

    -$38.27M
    CTEV annual working capital is -$38.27 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $107.62M
    CTEV annual cash flow from operations is $107.62 million

    Cash from operations 1-year change

    -37.33%
    CTEV annual cash flow from operations is down -37.33% year-on-year

    Cash from investing

    -$118.12M
    CTEV annual cash flow from investing activities is -$118.12 million

    Cash from investing 1-year change

    +52.71%
    CTEV annual cash flow from investing activities is up +52.71% year-on-year

    Cash from financing

    -$41.31M
    CTEV annual cash flow from financing activities is -$41.31 million

    Cash from financing 1-year change

    +77.17%
    CTEV annual cash flow from financing activities is up +77.17% year-on-year

    CAPEX

    CAPEX

    $118.12M
    CTEV annual capital expenditures is $118.12 million

    CAPEX 1-year change

    +8.52%
    CTEV annual capital expenditures is up +8.52% year-on-year

    Free Cash Flow

    Free cash flow

    -$10.51M
    CTEV annual free cash flow is -$10.51 million

    Free cash flow 1-year change

    -116.71%
    CTEV annual free cash flow is down -116.71% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    74.27%
    CTEV annual gross profit margin is 74.27%

    Operating margin

    10.63%
    CTEV annual operating profit margin is 10.63%

    Net margin

    -176.85%
    CTEV annual net profit margin is -176.85%

    ROA & ROE

    ROA

    -27.17%
    CTEV annual return on assets is -27.17%

    ROE

    -183.57%
    CTEV annual return on equity is -183.57%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CTEV price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CTEV price to earnings ratio is unknown

    PB Ratio

    PB ratio

    44.60
    CTEV price to book ratio is 44.60

    PB ratio Sector rank

    98.12%
    CTEV price to book ratio is higher than 98.12% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.71
    CTEV price to sales ratio is 0.71

    PS ratio Sector rank

    20.32%
    CTEV price to sales ratio is higher than 20.32% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $5.27B
    CTEV enterprise value is $5.27 billion

    Enterprise value Sector rank

    88.49%
    CTEV enterprise value is higher than 88.49% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -10.07
    CTEV EV/EBITDA is -10.07

    EV/EBITDA Sector rank

    12.58%
    CTEV EV/EBITDA is higher than 12.58% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.82
    CTEV annual current ratio is 0.82

    Quick ratio

    -
    CTEV annual quick ratio value is unknown

    Leverage

    Debt to equity

    53.83
    CTEV annual debt to equity ratio is 53.83

    Interest coverage ratio

    -4.43
    CTEV annual interest coverage ratio is -4.43

    Risk & Stability

    Piotroski F-Score

    5
    CTEV piotroski f-score is 5

    Altman Z-Score

    -1.26
    CTEV altman z-score is -1.26

    Analyst ratings

    Recent major analysts updates

    May 29, 25 Piper Sandler
    Overweight
    Mar 10, 25 Piper Sandler
    Neutral
    Jan 10, 25 Citigroup
    Neutral
    Sep 23, 24 Citigroup
    Neutral

    Institutional Ownership

    Screeners with CTEV included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Healthcare sector
    All stocks
    Stocks above analysts price target
    Stocks with high RSI
    • What is the ticker symbol for Claritev?
    • Does Claritev pay dividends?
    • What sector is Claritev in?
    • What industry is Claritev in?
    • What country is Claritev based in?
    • When did Claritev go public?
    • Is Claritev in the S&P 500?
    • Is Claritev in the NASDAQ 100?
    • Is Claritev in the Dow Jones?
    • When was Claritev's last earnings report?
    • When does Claritev report earnings?
    • Should I buy Claritev stock now?

    What is the ticker symbol for Claritev?

    The ticker symbol for Claritev is NYSE:CTEV

    Does Claritev pay dividends?

    No, Claritev does not pay dividends

    What sector is Claritev in?

    Claritev is in the Healthcare sector

    What industry is Claritev in?

    Claritev is in the Health Information Services industry

    What country is Claritev based in?

    Claritev is headquartered in United States

    When did Claritev go public?

    Claritev's initial public offering (IPO) was on April 3, 2020

    Is Claritev in the S&P 500?

    No, Claritev is not included in the S&P 500 index

    Is Claritev in the NASDAQ 100?

    No, Claritev is not included in the NASDAQ 100 index

    Is Claritev in the Dow Jones?

    No, Claritev is not included in the Dow Jones index

    When was Claritev's last earnings report?

    Claritev's most recent earnings report was on May 8, 2025

    When does Claritev report earnings?

    The next expected earnings date for Claritev is Aug 1, 2025

    Should I buy Claritev stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page